Arch Biopartners Arranges Non-Brokered Private Placement
23 déc. 2020 08h53 HE | Arch Biopartners
TORONTO, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), a clinical stage company developing new drug candidates for treating...
Arch Biopartners Receives Government of Canada Funding to Support Phase II Therapeutic Trial of Metablok for COVID-19
15 déc. 2020 12h52 HE | Arch Biopartners
Government of Canada contribution up to $6.7 MillionFunding from the department of Innovation, Science and Economic Development through the Strategic Innovation Fund and part of the Government of...
Government of Canada sets sights on transformative carbon-free energy technology in British Columbia
26 oct. 2018 12h52 HE | General Fusion
Investment will help create technology leading to 400 jobs and support innovation for emission-free and abundant energy BURNABY, British Columbia, Oct. 26, 2018 (GLOBE NEWSWIRE) -- In the face of...